An assessment of the informative value of data sharing statements in clinical trial registries
Abstract Background The provision of data sharing statements (DSS) for clinical trials has been made mandatory by different stakeholders. DSS are a device to clarify whether there is intention to share individual participant data (IPD). What is missing is a detailed assessment of whether DSS are pro...
Main Authors: | Christian Ohmann, Maria Panagiotopoulou, Steve Canham, Gerd Felder, Pablo Emilio Verde |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-03-01
|
Series: | BMC Medical Research Methodology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12874-024-02168-8 |
Similar Items
-
Evaluation of repositories for sharing individual-participant data from clinical studies
by: Rita Banzi, et al.
Published: (2019-03-01) -
Stakeholder perspectives on data sharing from pragmatic clinical trials: Unanticipated challenges for meeting emerging requirements
by: Stephanie R. Morain, et al.
Published: (2024-01-01) -
Social media attention and citations of published outputs from re-use of clinical trial data: a matched comparison with articles published in the same journals
by: N. Anthony, et al.
Published: (2021-06-01) -
Resource implications of preparing individual participant data from a clinical trial to share with external researchers
by: Catrin Tudur Smith, et al.
Published: (2017-07-01) -
Individual participant data sharing intentions and practices during the coronavirus disease-2019 pandemic: A rapid review
by: Prashanthi Kamath, et al.
Published: (2023-01-01)